NeuroPace (NPCE) Change in Accured Expenses (2020 - 2026)

NeuroPace's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$4.0 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 71.24% year-over-year to -$4.0 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 1045.45% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 355.17% from the prior year.
• Change in Accured Expenses retreated to -$4.0 million in Q1 2026 per NPCE's latest filing, from $1.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $2.6 million in Q3 2025 and bottomed at -$4.0 million in Q1 2026.
• The 5-year median for Change in Accured Expenses is $454000.0 (2024), against an average of $112823.5.
• Across the five-year window, Change in Accured Expenses soared 39975.0% in 2023 and plunged 366.43% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at -$136000.0 in 2022, then soared by 941.91% to $1.1 million in 2023, then tumbled by 124.8% to -$284000.0 in 2024, then surged by 459.86% to $1.0 million in 2025, then slumped by 490.9% to -$4.0 million in 2026.
• Per Business Quant, the three latest NPCE Change in Accured Expenses figures stand at -$4.0 million (Q1 2026), $1.0 million (Q4 2025), and $2.6 million (Q3 2025).